Watch Ticker

Vaxcyte, Inc. Common Stock

Go to Vaxcyte, Inc. Common Stock Website

$34.29

0.57 (1.69%)

Live

Previous Close

$33.72

Day Range

$33.3 - $34.5

Previous Day Range

$32.55 - $33.861

Market Cap

$4.3 billion USD

Day Vol.

332377

Previous Day Vol.

824502

Currency

USD

Primary Exchange

Nasdaq

Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat b...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Vandana Singh - Vaxcyte Plans To Drop Developing One Pneumococcal Conjugate Vaccine

Vaxcyte has selected the VAX-24 Mid-dose as the basis for advancing an optimized dose formulation to a potential Phase 3 program. The company plans to initiate an infant Phase 3 study with either VAX-24 or VAX-31 pending the VAX-31 infant Phase 2 study topline data results anticipated in mid-2026.

Related tickers: PCVX, PFE.

Read Full Article

N/A - Kuehn Law Encourages Investors of Vaxcyte, Inc. to Contact Law Firm

Kuehn Law, a shareholder litigation law firm, is investigating potential self-dealing by officers and directors of Vaxcyte, Inc. Shareholders may be entitled to damages and corporate governance reforms.

Related tickers: PCVX.

Read Full Article

Trending Tickers

Please sign in to view